Eventide Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-728,385
| Closed | -$18M | – | 153 |
|
|
2022
Q2 | $18M | Hold |
728,385
| – | – | 0.39% | 74 |
|
|
2022
Q1 | $18.3M | Sell |
728,385
-311,615
| -30% | -$7.81M | 0.29% | 89 |
|
|
2021
Q4 | $37.9M | Hold |
1,040,000
| – | – | 0.48% | 69 |
|
|
2021
Q3 | $17.8M | Sell |
1,040,000
-363,000
| -26% | -$6.21M | 0.23% | 101 |
|
|
2021
Q2 | $18.8M | Buy |
1,403,000
+843,000
| +151% | +$11.3M | 0.25% | 96 |
|
|
2021
Q1 | $28.7M | Buy |
560,000
+173,000
| +45% | +$8.86M | 0.43% | 76 |
|
|
2020
Q4 | $24M | Buy |
387,000
+90,000
| +30% | +$5.57M | 0.37% | 80 |
|
|
2020
Q3 | $16.3M | Buy |
297,000
+122,000
| +70% | +$6.69M | 0.32% | 85 |
|
|
2020
Q2 | $10.1M | Buy |
+175,000
| New | +$10.1M | 0.22% | 93 |
|